International Society for Magnetic Resonance in Medicine moves annual meeting online due to COVID-19

The International Society for Magnetic Resonance in Medicine has decided to transition this year’s annual meeting to a fully virtual format amid the ongoing pandemic.

The 2021 ISMRM Annual Meeting & Exhibition was set to take place May 15-20 as a hybrid in-person and online gathering. In its Friday decision, however, ISMRM said travel restrictions, quarantine mandates, occupation limits and other challenges would make it hard to accommodate those wanting to gather in Vancouver, British Columbia.

“Even though COVID-19 vaccines are being distributed to some who would attend an in-person annual meeting, these will not reach our entire membership early enough to make a May meeting possible,” President Tim Leiner and 2021 Program Chair Nicole Seiberlich said in a statement. “For all of these reasons, moving to an online meeting is prudent.”

Despite its disappointment, ISMRM said the 2021 conference will retain features of last year’s virtual meeting while adding additional opportunities, including enhanced interaction.

Many organizations were faced with similarly difficult decisions last year, with some such as HIMSS canceling altogether. And 2021 is off to a similar start. 

Just last week the Radiology Business Management Association announced it would delay its meeting by six months, but still retain its in-person format. Other groups, such as the American College of Radiology, will once again host an entirely online experience.

""

Matt joined Chicago’s TriMed team in 2018 covering all areas of health imaging after two years reporting on the hospital field. He holds a bachelor’s in English from UIC, and enjoys a good cup of coffee and an interesting documentary.

Around the web

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care. 

After three years of intermittent shortages of nuclear imaging tracer technetium-99m pyrophosphate, there are no signs of the shortage abating.

GE HealthCare said the price of iodine contrast increased by more than 200% between 2017 to 2023. Will new Chinese tariffs drive costs even higher?